In the context of China's population aging trend, the increase in prevalence is a demand factor that promotes the rapid development of the in vitro diagnostic industry. We focus on the supply-side factors such as technological advancement and policy change to promote the industry. The promotion of policies at this stage is more significant, which is reflected in the promotion of industry scale growth and the development of new formats.
Graded diagnosis and treatment have been established with a strong base. The diversion of a large number of patients with common diseases, frequently-occurring diseases and chronic diseases to primary medical institutions will significantly change the situation of patients in previous tertiary hospitals and excessive income. The development of grassroots institutions has effectively alleviated the contradiction of medical difficulties. The effective release of patient demand brings significant incremental business to domestic upstream product companies.
This year's national policy on the new ICL business from exploration to clear encouragement of development, the significance is to clarify the important position of ICL in the medical reform, break through the inherent interests of the medical industry , and help to increase the share of medium and long-term ICL in the medical examination market. .
YT-T13
YT-T13
Shenzhen Sunshine Technology Co.,Ltd , https://www.shenzhenyatwin.com